Operative intervention for recurrent adrenocortical cancer.

Operative intervention for recurrent adrenocortical cancer.

Item
http://www.wikidata.org/entity/Q38163088
Adrenocortical carcinoma: modern management and evolving treatment strategies.Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.Actual 10-year survivors following resection of adrenocortical carcinoma.Surgical management of adrenocortical tumours.Diagnosis, treatment and outcome of adrenocortical cancer.5th International ACC Symposium: Surgical Considerations in the Treatment of Adrenocortical Carcinoma: 5th International ACC Symposium Session: Who, When and What Combination?The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.Open adrenalectomy in the era of laparoscopic surgery: a review.Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal Network.Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma.
P2860

Operative intervention for recurrent adrenocortical cancer.

Item
http://www.wikidata.org/entity/Q38163088
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Operative intervention for recurrent adrenocortical cancer.
@en
type
label
Operative intervention for recurrent adrenocortical cancer.
@en
prefLabel
Operative intervention for recurrent adrenocortical cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Operative intervention for recurrent adrenocortical cancer.
@en
P2093
P304
P31
P356
10.1016/J.SURG.2013.06.033
P407
P433
P478
P577
P698